3Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology ofsevere sepsis in the United States:analysis of incidence, outcome,and associated costs of care [ J ]. Cnt Care Med, 2001,29 (7) :1303-1310.
4Gorissen C, Baumgarten R, de Gtoot M, et al. Analytical and clini-cal performance of three natriuretic peptide tests in the emergencydepartment room[ J ]. Clin Chem Lab Med, 2007,45 (5) :678-684.
5Varpula M, Pulkki K, Karlsson S, et al. Predictive valve of N-tem-inal pro-brain natriuretic peptide in severe sepsis and septic shock[J]
. Crit Care Med, 2007,35(5):1277-1283.
6Ammann P, Fehr T, Minder El, et al. Elevation of troponin I in sep-sis and septic shock[J]. Intens Care Med, 2001,27(6) :965-969.
7Metha NJ, Khan IA, Gupta V, et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock [ J ]. Int J Cardiol, 2004,95 ( 1 ) : 13-17.
8Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syn- dromes[J]. J Am Coll Cardiol, 2003,41 ( 11 ) :2004-2009.
9Januzzi JL, Morss A, Tung R, et al. Natriuretie peptide testing for the evaluation of critically ill patients with shock in the intensive care unit:a prospective cohort study[J]. Crit Care, 2006,10(2) :134.
8Waisbren BA. Bacteremia due to gram-negative bacilli other than the Salmonella: a clinical and therapeutic study [ J]. AMA Arch Intern Med, 1951, 88 (3) : 467-488.
9Werdan K, Schmidt H, Ebelt H, et al. Impaired regulation of cardiac sepsis, SIRS,MODS [ J]. Can J Physiol Pharmacol, 2009,87 (4) : 266-274.
10ty for patients in the intensive care unit: a comparison of artificial neural networks with logistic regression models [ J]. Crit Care Med, 2001, 29 (2) : 2913-296.
